PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 17597580-1 2007 Monoamine oxidase B (MAO-B) functions in the deamination of monoamines, including dopamine and norepinephrine. Norepinephrine 95-109 monoamine oxidase B Homo sapiens 0-19 17597580-1 2007 Monoamine oxidase B (MAO-B) functions in the deamination of monoamines, including dopamine and norepinephrine. Norepinephrine 95-109 monoamine oxidase B Homo sapiens 21-26 8678123-1 1996 The monoamine oxidases (MAO-A and MAO-B) are the enzymes primarily responsible for the degradation of amine neurotransmitters, such as dopamine, norepinephrine, and serotonin. Norepinephrine 145-159 monoamine oxidase B Homo sapiens 34-39 9730267-0 1998 The role of MAO-A and MAO-B in the metabolic degradation of noradrenaline in human arteries. Norepinephrine 60-73 monoamine oxidase B Homo sapiens 22-27 9432289-4 1997 The inhibition of MAO-A cause the rise of norepinephrine, dopamine and serotonin in the synaptic cleft, of MAO-B only of dopamine. Norepinephrine 42-56 monoamine oxidase B Homo sapiens 107-112 7721026-7 1994 MAO-B inhibitors can selectively and dramatically increase the level of beta-phenylethylamine, which has been shown to potentiate dopamine and noradrenaline function in the central nervous system. Norepinephrine 143-156 monoamine oxidase B Homo sapiens 0-5 33855088-4 2021 Results: The norepinephrine levels were markedly high in gastric cancer tissue, while the norepinephrine-degrading enzymes MAOA and MAOB showed low expression. Norepinephrine 90-104 monoamine oxidase B Homo sapiens 132-136 7159481-6 1982 In contrast, the MAO-B in human platelets deaminated l-norepinephrine more readily than serotonin. Norepinephrine 53-69 monoamine oxidase B Homo sapiens 17-22 7159481-7 1982 Thus, l-norepinephrine, like dopamine, should be regarded as a substrate for both MAO-A and MAO-B in vitro. Norepinephrine 6-22 monoamine oxidase B Homo sapiens 92-97 7159481-8 1982 The prominent role of MAO-B in norepinephrine degradation in primates may need to be considered in interpreting laboratory and clinical studies of clorgyline and other selective MAO-inhibiting drugs. Norepinephrine 31-45 monoamine oxidase B Homo sapiens 22-27 7995014-2 1994 Although not all features of its antiParkinson action are known, studies that used brains obtained at autopsy from patients who took l-deprenyl show that the selective inhibition of MAO-B with a concomitant increase of phenylethylamine and dopamine, but not of serotonin or noradrenaline, in the basal ganglia may be responsible for its mode of action. Norepinephrine 274-287 monoamine oxidase B Homo sapiens 182-187 3480939-2 1987 However, availability of other selective MAO-B inhibitors have clearly shown that this is not the case, since the "cheese effect" is associated with the selective inhibition of MAO-A, the enzyme responsible for intraneuronal oxidation of noradrenaline. Norepinephrine 238-251 monoamine oxidase B Homo sapiens 41-46 3008207-7 1986 As both serotonin and norepinephrine are preferentially metabolized by MAO-A rather than MAO-B, an increased availability of serotonin (the precursor of melatonin) or enhanced noradrenergic function might mediate the melatonin changes observed to follow MAO-A but not MAO-B inhibition. Norepinephrine 22-36 monoamine oxidase B Homo sapiens 89-94 3008207-7 1986 As both serotonin and norepinephrine are preferentially metabolized by MAO-A rather than MAO-B, an increased availability of serotonin (the precursor of melatonin) or enhanced noradrenergic function might mediate the melatonin changes observed to follow MAO-A but not MAO-B inhibition. Norepinephrine 22-36 monoamine oxidase B Homo sapiens 268-273 33855088-8 2021 The norepinephrine-degrading enzymes MAOA and MAOB have significant expression differences in cancer and normal tissue, and their missing or low expression may predict immune therapy outcomes for gastric cancer patients. Norepinephrine 4-18 monoamine oxidase B Homo sapiens 46-50 32942081-1 2020 Monoamine oxidases (MAO-A and MAO-B) are mammalian flavoenzyme, which catalyze the oxidative deamination of several neurotransmitters like norepinephrine, dopamine, tyramine, serotonin, and some other amines. Norepinephrine 139-153 monoamine oxidase B Homo sapiens 30-35 30341696-1 2018 In early 1920s, tyramine oxidase was discovered that metabolized tyramine and in 1933 Blaschko demonstrated that this enzyme also metabolized adrenaline, noradrenaline and dopamine. Norepinephrine 154-167 monoamine oxidase B Homo sapiens 16-32 31771069-3 2020 Catechol-O-methyltransferase (COMT) and monoamine oxidase B (MAOB) are the enzymes that regulate degradation of dopamine, while dopamine beta-hydroxylase (DBH) is involved in synthesis of noradrenaline. Norepinephrine 188-201 monoamine oxidase B Homo sapiens 40-59 31771069-3 2020 Catechol-O-methyltransferase (COMT) and monoamine oxidase B (MAOB) are the enzymes that regulate degradation of dopamine, while dopamine beta-hydroxylase (DBH) is involved in synthesis of noradrenaline. Norepinephrine 188-201 monoamine oxidase B Homo sapiens 61-65 29552556-1 2018 Monoamine oxidase B (MAO-B) catalyzes deamination of monoamines such as neurotransmitters dopamine and norepinephrine. Norepinephrine 103-117 monoamine oxidase B Homo sapiens 0-19 29552556-1 2018 Monoamine oxidase B (MAO-B) catalyzes deamination of monoamines such as neurotransmitters dopamine and norepinephrine. Norepinephrine 103-117 monoamine oxidase B Homo sapiens 21-26 22890201-2 2012 Both monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B) regulate neurochemistry by degrading monoamine neurotransmitters (serotonin, dopamine, and norepinephrine). Norepinephrine 156-170 monoamine oxidase B Homo sapiens 37-56 26593027-1 2012 Monoamine oxidase (MAO), which exists in two isozymic forms, MAO A and MAO B, is an important flavoenzyme responsible for the metabolism of amine neurotransmitters such as dopamine, serotonin, and norepinephrine. Norepinephrine 197-211 monoamine oxidase B Homo sapiens 71-76 22890201-2 2012 Both monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B) regulate neurochemistry by degrading monoamine neurotransmitters (serotonin, dopamine, and norepinephrine). Norepinephrine 156-170 monoamine oxidase B Homo sapiens 58-63 20485326-1 2010 Monoamine oxidases (MAO-A and MAO-B) have a key role in the degradation of amine neurotransmitters, such as dopamine, norepinephrine and serotonin. Norepinephrine 118-132 monoamine oxidase B Homo sapiens 30-35 20679667-5 2010 Affected males in this family showed an inherited hemizygous deletion restricted to NDP and two immediately telomeric genes, monoamine oxidase-B (MAO-B) and monoamine oxidase-A (MAO-A), which encode closely related enzymes that metabolize biogenic amines including serotonin, dopamine, and norepinephrine. Norepinephrine 290-304 monoamine oxidase B Homo sapiens 125-144 20679667-5 2010 Affected males in this family showed an inherited hemizygous deletion restricted to NDP and two immediately telomeric genes, monoamine oxidase-B (MAO-B) and monoamine oxidase-A (MAO-A), which encode closely related enzymes that metabolize biogenic amines including serotonin, dopamine, and norepinephrine. Norepinephrine 290-304 monoamine oxidase B Homo sapiens 146-151 18219438-1 2008 Our aim was to study fracture risk in users of various antidepressants (tricyclic antidepressants, selective serotonin reuptake inhibitors, and the group of other antidepressants including monoamine oxidase B inhibitors and drugs with effect on the norepinephrine system) and its relationship with effects on inhibition of the cholinergic and serotonin transporter system. Norepinephrine 249-263 monoamine oxidase B Homo sapiens 189-208